Effect of hyperglycemia and the aldose reductase inhibitor tolrestat on sural nerve biochemistry and morphometry in advanced diabetic peripheral polyneuropathy
- 30 September 1993
- journal article
- clinical trial
- Published by Elsevier in Journal of Diabetes and its Complications
- Vol. 7 (3) , 157-169
- https://doi.org/10.1016/1056-8727(93)90041-v
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Endoneurial microvessels in human diabetic neuropathy. Endothelial cell dysjunction and lack of treatment effect by aldose reductase inhibitorDiabetes, 1991
- Diabetic NeuropathyAnnual Review of Medicine, 1990
- Administration of an aldose reductase inhibitor induces a decrease of collagen fluorescence in diabetic rats.Journal of Clinical Investigation, 1988
- Report and Recommendations of the San Antonio Conference on Diabetic NeuropathyDiabetes, 1988
- Advanced Glycosylation End Products in Tissue and the Biochemical Basis of Diabetic ComplicationsNew England Journal of Medicine, 1988
- Histopathological heterogeneity of neuropathy in insulin-dependent and non-insulin-dependent diabetes, and demonstration of axo-glial dysjunction in human diabetic neuropathy.Journal of Clinical Investigation, 1988
- Fiber loss is primary and multifocal in sural nerves in diabetic polyneuropathyAnnals of Neurology, 1986
- Pathogenesis of diabetic neuropathyAnnals of Neurology, 1986
- Progression of subclinical polyneuropathy in young patients with Type 1 (insulin-dependent) diabetes: associations with glycaemic control and microangiopathy (microvascular complications)Diabetologia, 1986
- Diabetes Mellitus and Its Degenerative Complications: A Prospective Study of 4,400 Patients Observed Between 1947 and 1973Diabetes Care, 1978